閉経前不眠症に対する治療の有効性と安全性に関する体系的なレビューとメタ解析
ShiWei Song1, Hao Chen2, HongFang Fu3
1Department of Traditional Chinese Medicine, Sichuan Taikang Hospital, Chengdu, China.
Frontiers in neurology
|August 27, 2025
まとめ
治療は効果率と睡眠の質を向上させることで 閉経前不眠症を大幅に改善します さらに大規模な試験は,治療に関するより堅実な証拠のために推奨されます.
科学分野:
- 統合医療
- 女性 の 健康
- 睡眠医学
背景:
- 閉経前不眠症は 女性の身体的・精神的な健康に影響を及ぼす一般的な健康障害です
- 閉経前不眠症の唯一の治療法として 既存の研究は体系的なレビューを欠いている.
研究 の 目的:
- 閉経前不眠症の治療における治療のみの有効性と安全性を評価するメタ分析を行う.
- ランダム化制御試験 (RCT) の証拠を合成して,の有効性を決定する.
主な方法:
- 閉経前不眠症に関するRCTを 7つの主要データベースで検索しました
- 968人の参加者を含む9つのRCT.
- コクラン・ハンドブックを用いて研究の質を評価し,Rev Man 5. 4を用いてメタ分析を行った.
主要な成果:
- 治療は対照群と比較して有効率 (OR: 3. 30) を大幅に改善し,PSQIスコア (MD: - 3.26) を減少させた.
- 治療はFSH,KMI,5-HT,NE,MENQOL,早起きスコア,睡眠アクティグラフィに好影響を与えた.
- 血清E2濃度において有意な差異は認められなかったが,LH濃度は有意な低下を示した (MD: - 5. 42).
結論:
- 治療は閉経前不眠症の治療において有意な効果を示しています.
- より信頼性の高い結果を得るために,大規模な多センターの長期追跡試験を推奨しています.
- 実践的な成果を生み出すために 現実世界の治療の臨床研究を提唱しています
関連する概念動画
Management of Insomnia
320
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
320
Insomnia
124
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
124
Sedatives and Hypnotics Drugs: Miscellaneous Agents
241
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
241


